TriSalus Life Sciences, Inc. (TLSI) Q2 2024 Earnings

TLSI·Reported August 14, 2024·Before market open

TriSalus Life Sciences, Inc. reported Q2 2024 revenue of $7.4M, beat analyst consensus of $6.9M by $485.6K. Diluted EPS came in at $-0.21, beat the $-0.49 consensus by $0.28.

Revenue

$7.4Mbeat by $485.6K

Consensus: $6.9M

Diluted EPS

$-0.21beat by $0.28

Consensus: $-0.49

SEC Filings

Earnings release8-K not filed yet

Quarterly report10-Q · 0001826667-24-000039

Financial Snapshot

Trailing eight quarters through Q2 2024

View all metrics

Revenue

Net Income

Operating Cash Flow

EPS (Diluted)

Q2 2024 Earnings FAQ

Common questions about TriSalus Life Sciences, Inc.'s Q2 2024 earnings report.

TriSalus Life Sciences, Inc. (TLSI) reported Q2 2024 earnings on August 14, 2024 before market open.

TriSalus Life Sciences, Inc. reported revenue of $7.4M and diluted EPS of $-0.21 for Q2 2024.

Revenue beat the consensus estimate of $6.9M by $485.6K. EPS beat the consensus estimate of $-0.49 by $0.28.

You can read the 10-Q periodic report (0001826667-24-000039) directly on SEC EDGAR. The filing index links above go to sec.gov.